USPTO serial 50095252
CERESITY
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- —
- Law office
- —
What this means
Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.
Need help with CERESITY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
ALIAKSANDR LAZOUSKI
ALIAKSANDR LAZOUSKI LAZOUSKI IP LLC14726 Bowfin Ter.Lakewood Ranch, FL 34202United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable computer software for analyzing clinical trial protocols, identifying clinical trial design and operational risks, generating recommendations, and comparing alternative clinical trial designs in the field of clinical research; Downloadable computer simulation software for modeling modeling clinical trial designs and projected clinical trial outcomes; Downloadable computer software using machine learning for developing predictive models; Downloadable computer software for aggregating clinical trial data from disparate source systems and establishing data lineage and traceability to Clinical Data Interchange Standards Consortium (CDISC) data standards, namely, Study Data Tabulation Model (SDTM), Analysis Data Model (ADaM), and Clinical Data Acquisition Standards Harmonization (CDASH); Downloadable software for generating clinical data governance and metadata lineage reports | ACTIVE | — |
| 035 | Business data analysis services in the field of clinical trials; Providing business intelligence services in the fields of medical devices, pharmaceuticals and the life sciences; Statistical analysis and reporting services for business purposes; Analyzing and compiling business data for clinical trial protocol optimization, operational risk assessment, clinical trial metadata governance, and data governance reporting purposes; Business consulting and management in the field of clinical trials, namely, providing information management services | ACTIVE | — |
| 042 | Software as a service (SAAS) services, namely, hosting software for use by others for analyzing clinical trial protocols, identifying clinical trial design and operational risks, generating recommendations, and comparing alternative clinical trial designs in the field of clinical research; Providing online non-downloadable computer software platforms for analyzing clinical trial protocols, identifying clinical trial design and operational risks, generating evidence-backed recommendations, and comparing alternative clinical trial designs; Providing online non-downloadable software using machine learning for analyzing clinical trial protocol data, identifying clinical trial design and operational risks, and generating predictive metrics in the field of clinical research; Providing temporary use of online non-downloadable simulation software for modeling clinical trial designs and projected clinical trial outcomes; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence for creating complex data science analyses; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing temporary use of on-line non-downloadable software for aggregating and mapping clinical trial data from electronic data capture, laboratory, imaging, and other clinical source systems to Clinical Data Interchange Standards Consortium (CDISC) data standards; Software as a service (SAAS) services featuring software for managing clinical metadata governance, tracking data lineage, and performing automated quality control of clinical datasets; Providing on-line non-downloadable software for generating clinical data governance reports for use in regulatory submissions | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 8, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 8, 2026 | NWAP | NEW APPLICATION ENTERED | — |